Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review

The relationship between inflammation and venous thrombosis is not well understood. An inflammatory response may be both the cause and consequence of venous thromboembolism (VTE). In fact, several risk factors of VTE modulate thrombosis through inflammatory markers. Acute pulmonary embolism (PE) is...

Full description

Bibliographic Details
Main Authors: Francisco Galeano-Valle, Lucía Ordieres-Ortega, Crhistian Mario Oblitas, Jorge del-Toro-Cervera, Luis Alvarez-Sala-Walther, Pablo Demelo-Rodríguez
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/5/2627
_version_ 1797413448271790080
author Francisco Galeano-Valle
Lucía Ordieres-Ortega
Crhistian Mario Oblitas
Jorge del-Toro-Cervera
Luis Alvarez-Sala-Walther
Pablo Demelo-Rodríguez
author_facet Francisco Galeano-Valle
Lucía Ordieres-Ortega
Crhistian Mario Oblitas
Jorge del-Toro-Cervera
Luis Alvarez-Sala-Walther
Pablo Demelo-Rodríguez
author_sort Francisco Galeano-Valle
collection DOAJ
description The relationship between inflammation and venous thrombosis is not well understood. An inflammatory response may be both the cause and consequence of venous thromboembolism (VTE). In fact, several risk factors of VTE modulate thrombosis through inflammatory markers. Acute pulmonary embolism (PE) is burdened by a remarkable mortality rate, up to 34% in severely ill patients presenting with hemodynamic instability. Initial mortality risk stratification is based on hemodynamic instability. Patients with a situation of hemodynamic stability require immediate further risk assessment based on clinical, imaging, and circulating biomarkers, as well as the presence of comorbidities. Some inflammatory biomarkers have shown potential usefulness in the risk stratification of patients with VTE, especially acute PE. C-reactive protein on admission is associated with 30-day mortality and bleeding in VTE patients. P-selectin is associated with right ventricle dysfunction in PE patients and might be associated with VTE recurrences and the extension of thrombosis. Tissue factor microparticles are associated with VTE recurrence in cancer-associated thrombosis. Other inflammatory biomarkers present scarce evidence (inflammatory cytokines, erythrocyte sedimentation rate, fibrinogen, leukocyte count). In this manuscript, we will review the prognostic role of different inflammatory biomarkers available both for clinical practice and research in VTE patients.
first_indexed 2024-03-09T05:18:03Z
format Article
id doaj.art-52937422a04848428588429f7b013f34
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T05:18:03Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-52937422a04848428588429f7b013f342023-12-03T12:42:55ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01225262710.3390/ijms22052627Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative ReviewFrancisco Galeano-Valle0Lucía Ordieres-Ortega1Crhistian Mario Oblitas2Jorge del-Toro-Cervera3Luis Alvarez-Sala-Walther4Pablo Demelo-Rodríguez5Venous Thromboembolism Unit, Internal Medicine, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, SpainVenous Thromboembolism Unit, Internal Medicine, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, SpainVenous Thromboembolism Unit, Internal Medicine, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, SpainVenous Thromboembolism Unit, Internal Medicine, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, SpainSchool of Medicine, Universidad Complutense de Madrid, Plaza de Ramón y Cajal, s/n, 28040 Madrid, SpainVenous Thromboembolism Unit, Internal Medicine, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, SpainThe relationship between inflammation and venous thrombosis is not well understood. An inflammatory response may be both the cause and consequence of venous thromboembolism (VTE). In fact, several risk factors of VTE modulate thrombosis through inflammatory markers. Acute pulmonary embolism (PE) is burdened by a remarkable mortality rate, up to 34% in severely ill patients presenting with hemodynamic instability. Initial mortality risk stratification is based on hemodynamic instability. Patients with a situation of hemodynamic stability require immediate further risk assessment based on clinical, imaging, and circulating biomarkers, as well as the presence of comorbidities. Some inflammatory biomarkers have shown potential usefulness in the risk stratification of patients with VTE, especially acute PE. C-reactive protein on admission is associated with 30-day mortality and bleeding in VTE patients. P-selectin is associated with right ventricle dysfunction in PE patients and might be associated with VTE recurrences and the extension of thrombosis. Tissue factor microparticles are associated with VTE recurrence in cancer-associated thrombosis. Other inflammatory biomarkers present scarce evidence (inflammatory cytokines, erythrocyte sedimentation rate, fibrinogen, leukocyte count). In this manuscript, we will review the prognostic role of different inflammatory biomarkers available both for clinical practice and research in VTE patients.https://www.mdpi.com/1422-0067/22/5/2627biomarkersdeep vein thrombosisinflammationpulmonary embolismprognosticreactive C protein
spellingShingle Francisco Galeano-Valle
Lucía Ordieres-Ortega
Crhistian Mario Oblitas
Jorge del-Toro-Cervera
Luis Alvarez-Sala-Walther
Pablo Demelo-Rodríguez
Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
International Journal of Molecular Sciences
biomarkers
deep vein thrombosis
inflammation
pulmonary embolism
prognostic
reactive C protein
title Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
title_full Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
title_fullStr Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
title_full_unstemmed Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
title_short Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
title_sort inflammatory biomarkers in the short term prognosis of venous thromboembolism a narrative review
topic biomarkers
deep vein thrombosis
inflammation
pulmonary embolism
prognostic
reactive C protein
url https://www.mdpi.com/1422-0067/22/5/2627
work_keys_str_mv AT franciscogaleanovalle inflammatorybiomarkersintheshorttermprognosisofvenousthromboembolismanarrativereview
AT luciaordieresortega inflammatorybiomarkersintheshorttermprognosisofvenousthromboembolismanarrativereview
AT crhistianmariooblitas inflammatorybiomarkersintheshorttermprognosisofvenousthromboembolismanarrativereview
AT jorgedeltorocervera inflammatorybiomarkersintheshorttermprognosisofvenousthromboembolismanarrativereview
AT luisalvarezsalawalther inflammatorybiomarkersintheshorttermprognosisofvenousthromboembolismanarrativereview
AT pablodemelorodriguez inflammatorybiomarkersintheshorttermprognosisofvenousthromboembolismanarrativereview